Coherus BioSciences Receives Complete Response Letter from FDA for its Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)

Go back to Coherus BioSciences Receives Complete Response Letter from FDA for its Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)
Charming Shoppes (NASDAQ: CHRS) Delayed: 1.37 +0.02 (1.48%)
Previous Close $1.35    52 Week High $31.98 
Open $1.36    52 Week Low $12.04 
Day High $1.40    P/E N/A 
Day Low $1.35    EPS $-0.10 
Volume 695,144